Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
On Thursday, Centene Corporation (NYSE:CNC) outlined its 2025 financial guidance.
週四,森特公司(紐約證券交易所代碼:CNC)概述了其2025年財務指導。
For fiscal year 2025, the health insurance plan provider expects total revenues of $166.5 billion to $169.5 billion, compared to a consensus of $166.58 billion.
這家健康保險計劃提供商預計,2025財年的總收入爲1665億美元至1695億美元,而市場普遍的收入爲1665.8億美元。
The guidance includes premium and service revenues of $154.0 billion to $156.0 billion. The company expects GAAP EPS of greater than $6.19, with adjusted EPS of greater than $7.25 compared to the consensus of $6.97.
該指引包括1540億美元至1560億美元的保費和服務收入。該公司預計,GAAP每股收益將超過6.19美元,調整後的每股收益將超過7.25美元,而市場普遍預期爲6.97美元。
Also Read: Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
另請閱讀:唐納德·特朗普的第二個任期可能會重塑美國的醫療體系,對《平價醫療法案》和醫療保險產生重大影響
The company expects a Health benefits ratio (HBR) of 88.4% to 89.0%.
該公司預計健康福利比率(HBR)爲88.4%至89.0%。
The insurer forecasts a 2025 selling, general, and administrative (SG&A) expense ratio of 8.1% to 8.7%, with an adjusted SG&A expense ratio of 8.1% to 8.7%.
該保險公司預測,2025年的銷售、一般和管理(SG&A)費用比率爲8.1%至8.7%,調整後的銷售和收購費用比率爲8.1%至8.7%。
The company reaffirms its 2024 premium and service revenues guidance if $143.5 billion to $144.5 billion, HBR guidance if 88.3% to 88.5%, and adjusted diluted EPS guidance of greater than $6.80.
該公司重申其2024年保費和服務收入預期爲1435億美元至1445億美元,HBR預期爲88.3%至88.5%,調整後的攤薄後每股收益預期超過6.80美元。
"Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customers and providers, all while delivering on our financial commitments," said Chief Executive Officer of Centene, Sarah London.
「Centene是一個以使命爲導向的組織,致力於爲超過2800萬名成員提供高質量的結果,其中許多人是美國醫療條件最複雜、歷史上服務最差的人群。在過去的三年中,我們改善了核心業務,投資於客戶和提供商的體驗,同時兌現了我們的財務承諾。」 Centene首席執行官莎拉·倫敦說。
Full-year 2024 earnings will be reported on February 4, 2025.
2024 年全年收益將於 2025 年 2 月 4 日公佈。
Price Action: CNC stock is up 1.92% at $57.99 at the last check on Thursday.
價格走勢:在週四的最後一次支票中,CNC股價上漲1.92%,至57.99美元。
- Keros Therapeutics Loses 75% Value In A Single Session – Here's Why
- Keros Therapeutics 在單次療程中損失了 75% 的價值——這就是原因
譯文內容由第三人軟體翻譯。